2020
67-OR: Benefit of Reduced Hypoglycemia with Continuous Glucose Monitoring (CGM) Is Sustained through 12 Months among Young Children with Type 1 Diabetes (T1D)
VAN NAME M, MILLER K, KANAPKA L, TAMBORLANE W, DIMEGLIO L. 67-OR: Benefit of Reduced Hypoglycemia with Continuous Glucose Monitoring (CGM) Is Sustained through 12 Months among Young Children with Type 1 Diabetes (T1D). Diabetes 2020, 69 DOI: 10.2337/db20-67-or.Peer-Reviewed Original ResearchContinuous glucose monitoringCGM groupBlood glucose monitoringBehavioral interventionsEfficacy of CGMGlucose monitoringFamily behavioral interventionsType 1 diabetesYoung childrenEisai Inc.MannKind CorporationReduced hypoglycemiaSanofi USLess hypoglycemiaMedian ageMedian timeHarry B. Helmsley Charitable TrustTrial completionCGM useHypoglycemiaDurable reductionInsulin pumpBGM groupSimilar reductionWeeks
2018
Management of Hypertension and Hyperlipidemia in Youth with T2D
BEAULIEU L, CHENG P, KATZ M, LAFFEL L, TAMBORLANE W, VAN NAME M, BANSAL N, KOLLMAN C, GAL R. Management of Hypertension and Hyperlipidemia in Youth with T2D. Diabetes 2018, 67 DOI: 10.2337/db18-1342-p.Peer-Reviewed Original ResearchTreatment of hypertensionBoehringer Ingelheim PharmaceuticalsLifestyle changesMedtronic MiniMedBoehringer Ingelheim GmbHPatient-related barriersManagement of hypertensionUrban academic centerEli LillyAdditional cardiovascular diseaseSelf-reported practicesMannKind CorporationSanofi USCVD complicationsLifestyle modificationGlycemic controlPatient adherenceDiabetes careTreatment recommendationsCardiovascular diseaseHypertensionPatient's perspectiveDiabetes InstituteHyperlipidemiaPhysical activity